(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-04 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 340440
| Date | Daily Closing Price | Open | High | Low | Volume |
| 04 Wed Sep 2024 | 92.61 | 91.95 | 92.80 | 91.00 | 1.045 times |
| 03 Tue Sep 2024 | 92.53 | 94.80 | 96.50 | 91.76 | 1.214 times |
| 30 Fri Aug 2024 | 95.54 | 94.52 | 95.67 | 93.14 | 0.902 times |
| 30 Fri Aug 2024 | 95.54 | 94.52 | 95.67 | 93.14 | 0.902 times |
| 29 Thu Aug 2024 | 93.61 | 93.64 | 95.19 | 93.28 | 0.753 times |
| 28 Wed Aug 2024 | 92.75 | 93.15 | 93.90 | 92.42 | 1.33 times |
| 27 Tue Aug 2024 | 93.14 | 94.32 | 94.53 | 92.23 | 1.096 times |
| 26 Mon Aug 2024 | 95.08 | 94.55 | 95.40 | 93.43 | 0.831 times |
| 23 Fri Aug 2024 | 94.55 | 94.34 | 95.39 | 93.59 | 0.877 times |
| 22 Thu Aug 2024 | 93.51 | 94.84 | 96.21 | 93.12 | 0.773 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 92.7, but if it comes above 92.7, then a intra day buy could be more profitable.
If you take a sell trade below 92.7, then use 92.7 as stoploss and 91.3 as target. However if you take a buy trade in stock , then use 92.7 as stoploss and 93.84 as target.
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 89.35 |
| Upside Target | 95.67 |
| Upside Target | 96.21 |
| Upside Target | 96.50 |
| Upside Target | 100.67 |
| Upside Target | 106.56 |
| Upside Target | 108.40 |
| Upside Target | 111.02 |
| Upside Target | 111.42 |
| Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 90.24 |
| Downside Intraday Target | 87.87 |
| Upside Intraday Target | 95.74 |
| Upside Intraday Target | 98.87 |
| Upside Intraday Target | 93.37 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 04 Wed Sep 2024 | 92.61 | 94.80 | 96.50 | 91.00 | 2.505 times |
| 30 Fri Aug 2024 | 95.54 | 94.52 | 95.67 | 93.14 | 0.184 times |
| 30 Fri Aug 2024 | 95.54 | 94.55 | 95.67 | 92.23 | 0.961 times |
| 23 Fri Aug 2024 | 94.55 | 93.35 | 96.21 | 92.77 | 0.599 times |
| 16 Fri Aug 2024 | 93.49 | 94.44 | 96.21 | 91.55 | 0.608 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 04 Wed Sep 2024 | 92.61 | 94.80 | 96.50 | 91.00 | 0.048 times |
| 30 Fri Aug 2024 | 95.54 | 106.51 | 108.40 | 89.35 | 1.157 times |
| 31 Wed Jul 2024 | 108.30 | 107.68 | 121.90 | 106.56 | 1.132 times |
| 28 Fri Jun 2024 | 107.78 | 106.43 | 111.42 | 100.67 | 0.902 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 93.76 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 93.76 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.